Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis

被引:3
|
作者
Zhang, Suo [1 ,2 ]
Chen, Yu-Lan [1 ]
Liu, Cui-Lian [1 ]
Xie, Jing-Yi [1 ]
Sun, Bao-Dong [1 ]
Liu, Dong-Zhou [1 ]
机构
[1] Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Rheumatol & Immunol, Jinan Univ,Clin Med Coll 2,Shenzhen Peoples Hosp, Shenzhen, Peoples R China
[2] Shenzhen Second Peoples Hosp, Dept Rheumatol & Immunol, Shenzhen, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
IgA nephropathy; systemic autoimmune myopathies; dermatomyositis; anti- transcription intermediary factor-1 gamma antibody; dermatomyositis-specific antibodies; RENAL INVOLVEMENT; POLYMYOSITIS; AUTOANTIBODIES; SPECTRUM; GLOMERULONEPHRITIS; CLASSIFICATION; DISEASE; RISK; LOCI;
D O I
10.3389/fimmu.2022.757802
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1 gamma antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors' knowledge, this is the first case study describing a patient with anti-TIF1 gamma antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1 gamma-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1 gamma-positive dermatomyositis.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis
    Venalis, Paulius
    Selickaja, Sandra
    Lundberg, Karin
    Rugiene, Rita
    Lundberg, Ingrid E.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 648 - 651
  • [32] The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
    Oldroyd, Alexander
    Sergeant, Jamie C.
    New, Paul
    McHugh, Neil J.
    Betteridge, Zoe
    Lamb, Janine A.
    Ollier, William E.
    Cooper, Robert G.
    Chinoy, Hector
    Ahmed, Yasmeen
    Armstrong, Raymond
    Bernstein, Robert
    Black, Carol
    Bowman, Simon
    Bruce, Ian
    Butler, Robin
    Carty, John
    Chattopadhyay, Chandra
    Chelliah, Easwaradhas
    Clarke, Fiona
    Dawes, Peter
    Devlin, Joseph
    Edwards, Christopher
    Emery, Paul
    Fordham, John
    Fraser, Alexander
    Gaston, Hill
    Gordon, Patrick
    Griffiths, Bridget
    Gunawardena, Harsha
    Hall, Frances
    Harrison, Beverley
    Hay, Elaine
    Horden, Lesley
    Isaacs, John
    Jones, Adrian
    Kamath, Sanjeet
    Kennedy, Thomas
    Kitas, George
    Klimiuk, Peter
    Knights, Sally
    Lambert, John
    Lanyon, Peter
    Laxminarayan, Ramasharan
    Lecky, Bryan
    Luqmani, Raashid
    Marks, Jeffrey
    Martin, Michael
    McGonagle, Dennis
    McHugh, Neil
    RHEUMATOLOGY, 2019, 58 (04) : 650 - 655
  • [33] Anti-PM/Scl antibody-positive dermatomyositis in a Japanese patient: a case report and review of the literature
    Kohara, Aki
    Yanaba, Koichi
    Muro, Yoshinao
    Ito, Hideki
    Nakagawa, Hidemi
    Noda, Kentaro
    Kurosaka, Daitaro
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (12) : 2186 - 2189
  • [35] Changes in antibody titres in patients with anti transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis
    Abe, Yoshiyuki
    Ando, Taiki
    Matsushita, Masakazu
    Tada, Kurisu
    Yamaji, Ken
    Tamura, Naoto
    RHEUMATOLOGY, 2019, 58 (01) : 179 - 181
  • [36] Anti-TIF1-γ antibody-positive dermatomyositis
    Li, Chia-Lun
    Ma, Sheng-Hsiang
    Wu, Chen-Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2583 - 2584
  • [37] The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis
    Aussy, Audrey
    Freret, Manuel
    Gallay, Laure
    Bessis, Didier
    Vincent, Thierry
    Jullien, Denis
    Drouot, Laurent
    Jouen, Fabienne
    Joly, Pascal
    Marie, Isabelle
    Meyer, Alain
    Sibilia, Jean
    Bader-Meunier, Brigitte
    Hachulla, Eric
    Hamidou, Mohammed
    Hue, Sophie
    Charuel, Jean-Luc
    Fabien, Nicole
    Viailly, Pierre-Julien
    Allenbach, Yves
    Benveniste, Olivier
    Cordel, Nadege
    Boyer, Olivier
    Amoura, Zahir
    Aouizerate, Jessie
    Authier, Francois-Jerome
    Benhamou, Ygal
    Benichou, Jacques
    Cherqaoui, Bilade
    Chosidow, Olivier
    Debarbieux, Sebastien
    Fardet, Laurence
    Graveleau, Julie
    Kahn, Jean-Emmanuel
    Langlois, Vincent
    Levesque, Herve
    Martin, Jerome
    Martis, Nihal
    Masseau, Agathe
    Musset, Lucile
    Neel, Antoine
    Queyrel-Moranne, Viviane
    Terrier, Benjamin
    Vinzio, Stephan
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (08) : 1360 - 1370
  • [38] Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
    Korsten, Peter
    Seitz, Cornelia S.
    Sahlmann, Carsten O.
    Schmidt, Jens
    RHEUMATOLOGY, 2019, 58 (11) : 2071 - 2073
  • [39] Fulminant Course of Neuromyelitis Optica in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis: A Case Report
    Kang, You-Ri
    Kim, Kun-Hee
    Nam, Tai-Seung
    Lee, Kyung-Hwa
    Kang, Kyung Wook
    Lee, Seung-Jin
    Choi, Seok-Yong
    Chandrasekaran, Gopalakrishnan
    Kim, Myeong-Kyu
    FRONTIERS IN MEDICINE, 2020, 7
  • [40] A New Linked Set of Autoantibodies in Dermatomyositis: Anti-Mi-2 and Anti-Transcription Intermediary Factor (TIF) 1alpha.
    Satoh, Minoru
    Chan, Jason Y. F.
    Li, Yi
    Vazquez-Del Mercado, Monica
    Petri, Marcelo
    Jara, Luis J.
    Saavedra, Miguel A.
    Cruz-Reyes, Claudia
    Sobel, Eric S.
    Reeves, Westley H.
    Ceribelli, Angela
    Chan, Edward K. L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S829 - S829